We are live on ! Find out more
HCS

Himension Capital (Singapore) Portfolio holdings

AUM $1.63B
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+71.14%
1 Year Est. Return
+148.03%
3 Year Est. Return
+491.63%
5 Year Est. Return
+237.53%
10 Year Est. Return
–
AUM
$1.63B
AUM Growth
+$329M
Cap. Flow
-$222M
Cap. Flow %
-13.64%
Top 10 Hldgs %
72.7%
Holding
197
New
62
Increased
45
Reduced
60
Closed
29

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$82.8M
2
INTC icon
Intel
INTC
+$51.5M
3
AAPL icon
Apple
AAPL
+$39.2M
4
TSLA icon
Tesla
TSLA
+$38.3M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$26.8M

Sector Composition

Rank Sector Weight
1 Technology 77.45%
2 Materials 5.5%
3 Communication Services 4.28%
4 Energy 3.7%
5 Consumer Discretionary 2.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
151
Praxis Precision Medicines
PRAX
$8.01B
$444K 0.03%
+1,327
New +$420K
LHX icon
152
L3Harris
LHX
$44.4B
$444K 0.03%
1,527
+71
+5% +$22.6K
SRRK icon
153
Scholar Rock
SRRK
$5.62B
$425K 0.03%
+7,721
New +$373K
TNGX icon
154
Tango Therapeutics
TNGX
$4.12B
$413K 0.03%
+13,209
New +$327K
IMNM icon
155
Immunome
IMNM
$2.37B
$413K 0.03%
+19,477
New +$417K
DNLI icon
156
Denali Therapeutics
DNLI
$3.28B
$410K 0.03%
+15,949
New +$328K
ZETA icon
157
Zeta Global
ZETA
$8.13B
$402K 0.02%
+20,449
New +$379K
CVNA icon
158
Carvana
CVNA
$45.4B
$393K 0.02%
+5,969
New +$422K
CYTK icon
159
Cytokinetics
CYTK
$9.12B
$392K 0.02%
+4,601
New +$330K
TLN
160
Talen Energy Corp
TLN
$15.3B
$391K 0.02%
1,018
-623
-38% -$228K
BA icon
161
Boeing
BA
$152B
$376K 0.02%
1,738
-436
-20% -$97K
GLUE icon
162
Monte Rosa Therapeutics
GLUE
$961M
$355K 0.02%
+14,661
New +$277K
CRVS icon
163
Corvus Pharmaceuticals
CRVS
$919M
$325K 0.02%
+21,771
New +$302K
CAT icon
164
Caterpillar
CAT
$380B
$272K 0.02%
255
-327
-56% -$287K
GLXY
165
Galaxy Digital Inc
GLXY
$4.47B
$268K 0.02%
9,806
-12,899
-57% -$359K
TWST icon
166
Twist Bioscience
TWST
$12.5B
$266K 0.02%
2,581
-2,900
-53% -$189K
IREN icon
167
Iris Energy
IREN
$16B
$247K 0.02%
5,411
-5,753
-52% -$299K
OCS icon
168
Oculis Holding
OCS
$486M
$240K 0.01%
17,276
-1,650
-9% -$37.4K
BX icon
169
Blackstone
BX
$84.3B
– –
-986
Closed -$113K
CAG icon
170
Conagra Brands
CAG
$6.34B
– –
-6,993
Closed -$110K
CALM icon
171
Cal-Maine
CALM
$3.09B
– –
-1,398
Closed -$111K
CF icon
172
CF Industries
CF
$17.3B
– –
-192
Closed -$24.9K
COIN icon
173
Coinbase
COIN
$49.9B
– –
-31,821
Closed -$5.56M
CRWD icon
174
CrowdStrike
CRWD
$272B
– –
-1,052
Closed -$103K
FANG icon
175
Diamondback Energy
FANG
$51.9B
– –
-503
Closed -$99.5K

Similar funds

Himension Capital (Singapore)'s Q2 2026 Portfolio in Review

As of Q2 2026, Himension Capital (Singapore) held 197 positions worth $1.63B, up 25% from $1.3B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Himension Capital (Singapore) withdrew a net $222M in Q2 2026, closing 29 positions and reducing 60 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 77% of assets, up from 68% a quarter earlier, followed by Materials and Communication Services.

Against the trend, Himension Capital (Singapore) opened a new position in Tower Semiconductor worth $11.9M.

  • Himension Capital (Singapore)'s largest Q2 2026 buy was Tower Semiconductor: 45,487 shares worth $11.9M.
  • Himension Capital (Singapore) added most to ASML in Q2 2026, an estimated $40M increase.
  • Himension Capital (Singapore)'s biggest Q2 2026 reduction was NVIDIA, cutting an estimated $82.8M.
  • Himension Capital (Singapore) fully exited iShares 20+ Year Treasury Bond ETF in Q2 2026, selling an estimated $26.8M.
  • Himension Capital (Singapore)'s ten largest holdings make up 73% of its $1.63B portfolio in Q2 2026.
  • Himension Capital (Singapore) opened 62 new positions and closed 29 in Q2 2026.
  • Himension Capital (Singapore)'s portfolio value rose 25% quarter-over-quarter to $1.63B.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.